Background: Research conducted on young Israeli travellers has pointed to high substance usage rates. For some drug-using backpackers, actual extraction and rescue from their trip abroad is necessary. This study represents a first attempt to explore the influence of geographic region in which rescue occurs, cause for rescue and gender and age differences among Israeli rescuees.
Methods: Sub-analysis of all logs of individual rescuees during a 5-year period from 2011 to 2016 ( N = 86) included 66 men and 20 women, with an average age of 27.83 (SD = 7.86).
Results: The findings demonstrate that Israelis are most frequently rescued from South and Southeast Asia (57%) followed by Europe (22%), South America (17%), North America (2.3%) and Africa (1.2%). India was the country with the highest rate of rescue incidents ( N = 36) followed by Thailand ( N = 8) and the Netherlands ( N = 5). The most common cause for rescue was substance abuse (87%). However, significant regional differences were found based on the variable of age ( F = 3.21, df = 3,50, P < 0.05). The youngest rescuees were evacuated from South America ( M = 24.20 years, SD = 3.8), while the oldest were from Europe ( M = 32.86 years, SD = 10.9). The most frequent mental diagnosis for rescuees was acute psychosis due to substance use disorder (81%) and bipolar disorder, manic subtype due to substance abuse (7%). Significant gender differences were found among rescuees diagnosed with bipolar disorder, manic type: 25% were female, while men only accounted for 1.5% ( χ 2 = 61.70, df = 24, P < 0.0001).
Conclusions: Region, age and gender of young travellers should be taken into consideration when thinking about induced acute psychosis caused by substance use. Policymakers need to consider prevention and harm reduction interventions relevant to this risk group.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/jtm/tax045 | DOI Listing |
Nat Med
January 2025
Melanoma Institute Australia, The University of Sydney; Faculty of Medicine and Health, The University of Sydney; and Mater and Royal North Shore Hospitals, Sydney, New South Wales, Australia.
Neoadjuvant immunotherapies have shown antitumor activity in melanoma. Substudy 02C of the global, rolling-arm, phase 1/2, adaptive-design KEYMAKER-U02 trial is evaluating neoadjuvant pembrolizumab (anti-PD-1) alone or in combination, followed by adjuvant pembrolizumab, for stage IIIB-D melanoma. Here we report results from the first three arms: pembrolizumab plus vibostolimab (anti-TIGIT), pembrolizumab plus gebasaxturev (coxsackievirus A21) and pembrolizumab monotherapy.
View Article and Find Full Text PDFLancet
January 2025
Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany.
Lancet Oncol
November 2024
Helsicore Israeli Georgian Medical Research Clinic, Tbilisi, Georgia.
Behav Sci (Basel)
October 2024
Department of Psychology, Oakland University, Rochester, MI 48306, USA.
This study aimed to examine the role of travel-related motivations and preferences for activities (such as learning about local culture, relaxation and entertainment, status and social recognition, escape and curiosity, and experience) in the relationship between narcissistic personality traits and the preference for luxury tourism versus cultural tourism. A sample of 1342 Israeli community members was analyzed. The methodology utilized parallel mediation analyses to assess how different forms of narcissism (extraverted, antagonistic, neurotic, and communal) were associated with the desire for luxury tourism over cultural tourism, as mediated by various travel-related motivations.
View Article and Find Full Text PDFAm J Trop Med Hyg
January 2025
Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona, Israel.
We present the investigation of a Burkholderia pseudomallei strain isolated from the urine of a 56-year-old male returning from a recreational trip to Thailand. The patient initially presented with fever and chills, and lobar as well as bladder and prostate involvement was demonstrated on imaging. Treatment first involved trimethoprim-sulfamethoxazole, the backbone of melioidosis therapy, but was discontinued upon the discovery of resistance to the drug through antimicrobial sensitivity testing via broth microdilution.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!